Literature DB >> 24147506

Technique to displace bowel loops in MRI-guided high-intensity focused ultrasound ablation of fibroids in the anteverted or anteflexed uterus.

Min Jung Park1, Young-Sun Kim, Hyunchul Rhim, Hyo Keun Lim.   

Abstract

OBJECTIVE: In MRI-guided high-intensity focused ultrasound ablation of uterine fibroids, bowel interposition in the sonication path is often problematic. The purpose of this article is to discuss a bowel-manipulation technique to displace the bowel loop, which consisted of sequential applications of urinary bladder filling, rectal filling, and urinary bladder emptying.
CONCLUSION: This technique contributed to a decreased screening failure rate and succeeded in consistently displacing the bowel loop, thus allowing safe treatment of fibroids in the anteverted or anteflexed uterus.

Mesh:

Year:  2013        PMID: 24147506     DOI: 10.2214/AJR.12.10081

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

Review 1.  Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids.

Authors:  Nguyen Minh Duc; Bilgin Keserci
Journal:  Diagn Interv Radiol       Date:  2018-09       Impact factor: 2.630

Review 2.  Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.

Authors:  G Pron
Journal:  Ont Health Technol Assess Ser       Date:  2015-03-01

3.  Protein-based nanoplatform for detection of tumorigenic polyps in the colon via noninvasive mucosal routes.

Authors:  Chun-Chieh Chen; Mo A Baikoghli; R Holland Cheng
Journal:  Pharm Pat Anal       Date:  2021-01-20

4.  Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids: Effect of Bowel Interposition on Procedure Feasibility and a Unique Bowel Displacement Technique.

Authors:  Young-Sun Kim; Hyo Keun Lim; Hyunchul Rhim
Journal:  PLoS One       Date:  2016-05-17       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.